Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence.
Varco-Merth B, Chaunzwa M, Duell DM, Marenco A, Goodwin W, Dannay R, Nekorchuk M, Shao D, Busman-Sahay K, Fennessey CM, Silipino L, Hull M, Bosche WJ, Fast R, Oswald K, Shoemaker R, Bochart R, MacAllister R, Labriola CS, Smedley JV, Axthelm MK, Davenport MP, Edlefsen PT, Estes JD, Keele BF, Lifson JD, Lewin SR, Picker LJ, Okoye AA.
Varco-Merth B, et al. Among authors: keele bf.
PLoS Pathog. 2024 Aug 22;20(8):e1012496. doi: 10.1371/journal.ppat.1012496. eCollection 2024 Aug.
PLoS Pathog. 2024.
PMID: 39173097
Free PMC article.